Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saccharomyces boulardii plus standard triple therapy for Helicobacter pylori eradication
ChiCTR-TRC-13003348Phase 4Completed
- Sponsor
- Army Specialized Medical Center
- Start
- Jun 2013
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of saccharomyces boulardii in Helicobacter pylori infection, gastritis and duodenal ulcer (2 arms), sponsored by Army Specialized Medical Center. Primary endpoint: Helicobacter pylori eradication rate. Started Jun 2013; status: completed.
02
Drugs
saccharomyces boulardii
03
Conditions
Helicobacter pylori infectiongastritisduodenal ulcer
Beyond the preview
Go deeper on ChiCTR-TRC-13003348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003348.